Results
1 -
8 of
8ICER releases list of potential review topics in 2018, PharmacoEconomics & Outcomes News Mukoviszidose: die Ursache, nicht die Symptome behandeln, P??diatrie ICER posts scoping document on tezacaftor and lumacaftor, PharmacoEconomics & Outcomes News ICER to develop report on cystic??fibrosis treatments, PharmacoEconomics & Outcomes News ICER releases draft report on cystic fibrosis therapies, PharmacoEconomics & Outcomes News Targeted therapies to improve CFTR function in cystic fibrosis, Genome Medicine Personalizing cystic fibrosis in vitro, Science-Business eXchange Rationalizing CF combos, Science-Business eXchange